Clinical Trial Update: Signatera Assessment in Early-Stage Endometrial Cancer [NA]

View source ↗

Summary

ClinicalTrials.gov entry indicates a Signatera assessment in early-stage endometrial cancer, with the study currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Signatera

Snippet

Sponsor: Natera, Inc. | Conditions: Endometrial Cancer | NA | Status: NOT_YET_RECRUITING